{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:57:51Z","timestamp":1790323071283,"version":"4.1.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Project of Hunan Provincial Natural Science Foundation","award":["No. 2018JJ3782"],"award-info":[{"award-number":["No. 2018JJ3782"]}]},{"name":"Changsha Science and Technology Bureau Foundation","award":["No. kq1701085"],"award-info":[{"award-number":["No. kq1701085"]}]},{"name":"the Fundamental Research Funds for the Central Universities of Central South University","award":["No. 2018zzts952"],"award-info":[{"award-number":["No. 2018zzts952"]}]},{"name":"the Fundamental Research Funds for the Central Universities of Central South University","award":["No. 2018zzts937"],"award-info":[{"award-number":["No. 2018zzts937"]}]},{"name":"Graduate research project of central south university","award":["No. 2018-75"],"award-info":[{"award-number":["No. 2018-75"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11033-019-05123-9","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T09:04:32Z","timestamp":1571043872000},"page":"737-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Expression and function of FRA1 protein in tumors"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-7290","authenticated-orcid":false,"given":"Xiaoyan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1932-8052","authenticated-orcid":false,"given":"Songshu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"issue":"5","key":"5123_CR1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1128\/Mcb.8.5.2063","volume":"8","author":"DR Cohen","year":"1988","unstructured":"Cohen DR, Curran T (1988) Fra-1\u2014a serum-inducible, cellular immediate-early gene that encodes a Fos-Related antigen. Mol Cell Biol 8(5):2063\u20132069. \nhttps:\/\/doi.org\/10.1128\/Mcb.8.5.2063","journal-title":"Mol Cell Biol"},{"issue":"2","key":"5123_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1101\/gad.3.2.173","volume":"3","author":"DR Cohen","year":"1989","unstructured":"Cohen DR, Ferreira PCP, Gentz R, Franza BR, Curran T (1989) The product of a Fos-Related Gene, Fra-1, binds cooperatively to the Ap-1 Site with Jun\u2014transcription factor Ap-1 is comprised of multiple protein complexes. Gene Dev 3(2):173\u2013184. \nhttps:\/\/doi.org\/10.1101\/gad.3.2.173","journal-title":"Gene Dev"},{"issue":"3","key":"5123_CR3","first-page":"249","volume":"5","author":"M Matsui","year":"1990","unstructured":"Matsui M, Tokuhara M, Konuma Y, Nomura N, Ishizaki R (1990) Isolation of human Fos-Related genes and their expression during monocyte-macrophage differentiation. Oncogene 5(3):249\u2013255","journal-title":"Oncogene"},{"issue":"11","key":"5123_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3(11):859\u2013868. \nhttps:\/\/doi.org\/10.1038\/nrc1209","journal-title":"Nat Rev Cancer"},{"key":"5123_CR5","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","volume":"8","author":"H Gazon","year":"2017","unstructured":"Gazon H, Barbeau B, Mesnard JM, Peloponese JM Jr (2017) Hijacking of the AP-1 signaling pathway during development of ATL. Front Microbiol 8:2686. \nhttps:\/\/doi.org\/10.3389\/fmicb.2017.02686","journal-title":"Front Microbiol"},{"issue":"3","key":"5123_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0092-8674(88)90024-4","volume":"55","author":"T Curran","year":"1988","unstructured":"Curran T, Franza BR Jr (1988) Fos and Jun: the AP-1 connection. Cell 55(3):395\u2013397","journal-title":"Cell"},{"issue":"6","key":"5123_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0092-8674(87)90611-8","volume":"49","author":"P Angel","year":"1987","unstructured":"Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49(6):729\u2013739","journal-title":"Cell"},{"issue":"12","key":"5123_CR8","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1128\/Mcb.13.12.7429","volume":"13","author":"R Wisdom","year":"1993","unstructured":"Wisdom R, Verma IM (1993) Transformation by Fos proteins requires a C-terminal transactivation domain. Mol Cell Biol 13(12):7429\u20137438. \nhttps:\/\/doi.org\/10.1128\/Mcb.13.12.7429","journal-title":"Mol Cell Biol"},{"issue":"12","key":"5123_CR9","first-page":"1755","volume":"5","author":"E Ito","year":"1990","unstructured":"Ito E, Sweterlitsch LA, Tran PBV, Rauscher FJ, Narayanan R (1990) Inhibition of Pc-12 cell-differentiation by the immediate early gene Fra-1. Oncogene 5(12):1755\u20131760","journal-title":"Oncogene"},{"issue":"11","key":"5123_CR10","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1073\/pnas.92.11.4972","volume":"92","author":"K Yoshioka","year":"1995","unstructured":"Yoshioka K, Deng TL, Cavigelli M, Karin M (1995) Antitumor promotion by phenolic antioxidants\u2014inhibition of Ap-1 activity through induction of Fra expression. Proc Natl Acad Sci USA 92(11):4972\u20134976. \nhttps:\/\/doi.org\/10.1073\/pnas.92.11.4972","journal-title":"Proc Natl Acad Sci USA"},{"issue":"48","key":"5123_CR11","doi-asserted-by":"publisher","first-page":"47423","DOI":"10.1074\/jbc.M303505200","volume":"278","author":"P Adiseshaiah","year":"2003","unstructured":"Adiseshaiah P, Papaiahgari SR, Vuong H, Kalvakolanu DV, Reddy SP (2003) Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells. J Biol Chem 278(48):47423\u201347433. \nhttps:\/\/doi.org\/10.1074\/jbc.M303505200","journal-title":"J Biol Chem"},{"issue":"12","key":"5123_CR12","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1128\/Mcb.23.12.4401-4415.2003","volume":"23","author":"L Casalino","year":"2003","unstructured":"Casalino L, De Cesare D, Verde P (2003) Accumulation of fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 23(12):4401\u20134415. \nhttps:\/\/doi.org\/10.1128\/Mcb.23.12.4401-4415.2003","journal-title":"Mol Cell Biol"},{"key":"5123_CR13","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20160643","author":"L Zhang","year":"2017","unstructured":"Zhang L, Liu H, Mu X, Cui J, Peng Z (2017) Dysregulation of Fra1 expression by Wnt\/beta-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition. Biosci Rep. \nhttps:\/\/doi.org\/10.1042\/BSR20160643","journal-title":"Biosci Rep"},{"issue":"4","key":"5123_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/carcin\/bgv017","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, Ren GP, Wang TY, Chen YX, Gong CJ, Bai YF, Wang B, Qi HY, Shen J, Zhu LJ, Qian C, Lai MD, Shao JM (2015) Aberrantly expressed Fra-1 by IL-6\/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Carcinogenesis 36(4):459\u2013468. \nhttps:\/\/doi.org\/10.1093\/carcin\/bgv017","journal-title":"Carcinogenesis"},{"issue":"2","key":"5123_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.canlet.2016.03.010","volume":"375","author":"F Cheng","year":"2016","unstructured":"Cheng F, Su L, Yao C, Liu L, Shen J, Liu C, Chen X, Luo Y, Jiang L, Shan J, Chen J, Zhu W, Shao J, Qian C (2016) SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression. Cancer Lett 375(2):274\u2013283. \nhttps:\/\/doi.org\/10.1016\/j.canlet.2016.03.010","journal-title":"Cancer Lett"},{"issue":"6","key":"5123_CR16","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.cell.2009.07.031","volume":"138","author":"A Zippo","year":"2009","unstructured":"Zippo A, Serafini R, Rocchigiani M, Pennacchini S, Krepelova A, Oliviero S (2009) Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138(6):1122\u20131136. \nhttps:\/\/doi.org\/10.1016\/j.cell.2009.07.031","journal-title":"Cell"},{"issue":"11","key":"5123_CR17","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1128\/MCB.01776-06","volume":"27","author":"J Basbous","year":"2007","unstructured":"Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M (2007) Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1\/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol 27(11):3936\u20133950. \nhttps:\/\/doi.org\/10.1128\/MCB.01776-06","journal-title":"Mol Cell Biol"},{"key":"5123_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2016.10.038","volume":"385","author":"K Belguise","year":"2017","unstructured":"Belguise K, Cherradi S, Sarr A, Boissiere F, Boulle N, Simony-Lafontaine J, Choesmel-Cadamuro V, Wang X, Chalbos D (2017) PKCtheta-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration. Cancer Lett 385:97\u2013107. \nhttps:\/\/doi.org\/10.1016\/j.canlet.2016.10.038","journal-title":"Cancer Lett"},{"issue":"9","key":"5123_CR19","first-page":"2537","volume":"9","author":"MC Gruda","year":"1994","unstructured":"Gruda MC, Kovary K, Metz R, Bravo R (1994) Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9(9):2537\u20132547","journal-title":"Oncogene"},{"issue":"47","key":"5123_CR20","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1038\/onc.2011.659","volume":"31","author":"K Belguise","year":"2012","unstructured":"Belguise K, Milord S, Galtier F, Moquet-Torcy G, Piechaczyk M, Chalbos D (2012) The PKCtheta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene 31(47):4889\u20134897. \nhttps:\/\/doi.org\/10.1038\/onc.2011.659","journal-title":"Oncogene"},{"issue":"3","key":"5123_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2013.08.005","volume":"24","author":"WL Tam","year":"2013","unstructured":"Tam WL, Lu H, Buikhuisen J, Soh BS, Lim E, Reinhardt F, Wu ZJ, Krall JA, Bierie B, Guo W, Chen X, Liu XS, Brown M, Lim B, Weinberg RA (2013) Protein kinase C alpha is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell 24(3):347\u2013364. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2013.08.005","journal-title":"Cancer Cell"},{"issue":"25","key":"5123_CR22","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1038\/s41388-019-0763-0","volume":"38","author":"T Wang","year":"2019","unstructured":"Wang T, Song P, Zhong T, Wang X, Xiang X, Liu Q, Chen H, Xia T, Liu H, Niu Y, Hu Y, Xu L, Shao Y, Zhu L, Qi H, Shen J, Hou T, Fodde R, Shao J (2019) The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties. Oncogene 38(25):4932\u20134947. \nhttps:\/\/doi.org\/10.1038\/s41388-019-0763-0","journal-title":"Oncogene"},{"issue":"2","key":"5123_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.biochi.2007.07.016","volume":"90","author":"J Basbous","year":"2008","unstructured":"Basbous J, Jariel-Encontre I, Gomard T, Bossis G, Piechaczyk M (2008) Ubiquitin-independent-versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer? Biochimie 90(2):296\u2013305. \nhttps:\/\/doi.org\/10.1016\/j.biochi.2007.07.016","journal-title":"Biochimie"},{"issue":"14","key":"5123_CR24","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/onc.2011.375","volume":"31","author":"JL Pakay","year":"2012","unstructured":"Pakay JL, Diesch J, Gilan O, Yip YY, Sayan E, Kolch W, Mariadason JM, Hannan RD, Tulchinsky E, Dhillon AS (2012) A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells. Oncogene 31(14):1817\u20131824. \nhttps:\/\/doi.org\/10.1038\/onc.2011.375","journal-title":"Oncogene"},{"issue":"6824","key":"5123_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37\u201340. \nhttps:\/\/doi.org\/10.1038\/35065000","journal-title":"Nature"},{"issue":"24","key":"5123_CR26","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1242\/jcs.00812","volume":"116","author":"E Vial","year":"2003","unstructured":"Vial E, Marshall CJ (2003) Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 116(24):4957\u20134963. \nhttps:\/\/doi.org\/10.1242\/jcs.00812","journal-title":"J Cell Sci"},{"issue":"6","key":"5123_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cels.2017.10.019","volume":"5","author":"TE Gillies","year":"2017","unstructured":"Gillies TE, Pargett M, Minguet M, Davies AE, Albeck JG (2017) Linear integration of ERK activity predominates over persistence detection in Fra-1 regulation. Cell Syst 5(6):549\u2013563. \nhttps:\/\/doi.org\/10.1016\/j.cels.2017.10.019","journal-title":"Cell Syst"},{"issue":"9","key":"5123_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrm906","volume":"3","author":"KA Gallo","year":"2002","unstructured":"Gallo KA, Johnson GL (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Bio 3(9):663\u2013672. \nhttps:\/\/doi.org\/10.1038\/nrm906","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"23","key":"5123_CR29","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1038\/onc.2013.258","volume":"33","author":"J Yang","year":"2014","unstructured":"Yang J, Zhang Z, Chen C, Liu Y, Si Q, Chuang TH, Li N, Gomez-Cabrero A, Reisfeld RA, Xiang R, Luo Y (2014) MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene. Oncogene 33(23):3014\u20133023. \nhttps:\/\/doi.org\/10.1038\/onc.2013.258","journal-title":"Oncogene"},{"issue":"5","key":"5123_CR30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3892\/mmr.2014.2010","volume":"9","author":"SS Xiao","year":"2014","unstructured":"Xiao SS, Zhou YH, Jiang JF, Yuan L, Xue M (2014) CD44 affects the expression level of FOS-like antigen 1 in cervical cancer tissues. Mol Med Rep 9(5):1667\u20131674. \nhttps:\/\/doi.org\/10.3892\/mmr.2014.2010","journal-title":"Mol Med Rep"},{"issue":"46","key":"5123_CR31","doi-asserted-by":"publisher","first-page":"40104","DOI":"10.1074\/jbc.C111.296707","volume":"286","author":"Y Jin","year":"2011","unstructured":"Jin Y, Wang C, Liu XQ, Mu WB, Chen ZJ, Yu DS, Wang AX, Dai Y, Zhou XF (2011) Molecular characterization of the MicroRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem 286(46):40104\u201340109. \nhttps:\/\/doi.org\/10.1074\/jbc.C111.296707","journal-title":"J Biol Chem"},{"key":"5123_CR32","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.2147\/OTT.S114609","volume":"9","author":"N Zhang","year":"2016","unstructured":"Zhang N, Shen Q, Zhang P (2016) miR-497 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1. Onco Targ Ther 9:6597\u20136604. \nhttps:\/\/doi.org\/10.2147\/OTT.S114609","journal-title":"Onco Targ Ther"},{"issue":"6","key":"5123_CR33","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1002\/jcb.26739","volume":"119","author":"X Chen","year":"2018","unstructured":"Chen X, Zhao M, Huang J, Li Y, Wang S, Harrington CA, Qian DZ, Sun XX, Dai MS (2018) microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1. J Cell Biochem 119(6):4945\u20134956. \nhttps:\/\/doi.org\/10.1002\/jcb.26739","journal-title":"J Cell Biochem"},{"key":"5123_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-015-0650-6","volume":"13","author":"J Wu","year":"2015","unstructured":"Wu J, Ji A, Wang X, Zhu Y, Yu Y, Lin Y, Liu Y, Li S, Liang Z, Xu X, Zheng X, Xie L (2015) MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells. J Transl Med 13:289. \nhttps:\/\/doi.org\/10.1186\/s12967-015-0650-6","journal-title":"J Transl Med"},{"issue":"36","key":"5123_CR35","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/onc.2012.432","volume":"32","author":"S Yang","year":"2013","unstructured":"Yang S, Li Y, Gao J, Zhang T, Li S, Luo A, Chen H, Ding F, Wang X, Liu Z (2013) MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32(36):4294\u20134303. \nhttps:\/\/doi.org\/10.1038\/onc.2012.432","journal-title":"Oncogene"},{"issue":"3","key":"5123_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/carcin\/bgr304","volume":"33","author":"J Wu","year":"2012","unstructured":"Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF (2012) MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 33(3):519\u2013528. \nhttps:\/\/doi.org\/10.1093\/carcin\/bgr304","journal-title":"Carcinogenesis"},{"issue":"25","key":"5123_CR37","doi-asserted-by":"publisher","first-page":"13789","DOI":"10.1039\/c8ra00907d","volume":"8","author":"Y Xia","year":"2018","unstructured":"Xia Y, Deng X, Cao M, Liu S, Zhang X, Xiao X, Shen S, Hu Q, Sheng W (2018) Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy. RSC Adv 8(25):13789\u201313797. \nhttps:\/\/doi.org\/10.1039\/c8ra00907d","journal-title":"RSC Adv"},{"issue":"246","key":"5123_CR38","doi-asserted-by":"publisher","first-page":"40104","DOI":"10.1074\/jbc.C111.296707","volume":"286","author":"Y Jin","year":"2011","unstructured":"Jin Y, Wang C, Liu X, Mu W, Chen Z, Yu D, Wang A, Dai Y, Zhou X (2011) Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem 286(246):40104\u201340109. \nhttps:\/\/doi.org\/10.1074\/jbc.C111.296707","journal-title":"J Biol Chem"},{"issue":"186","key":"5123_CR39","doi-asserted-by":"publisher","first-page":"pt5","DOI":"10.1126\/scisignal.2002258","volume":"4","author":"S Stinson","year":"2011","unstructured":"Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O\u2019Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D (2011) miR-221\/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal 4(186):pt5. \nhttps:\/\/doi.org\/10.1126\/scisignal.2002258","journal-title":"Sci Signal"},{"issue":"9","key":"5123_CR40","doi-asserted-by":"publisher","first-page":"e2384","DOI":"10.1038\/cddis.2016.289","volume":"7","author":"J Wu","year":"2016","unstructured":"Wu J, Sun Y, Zhang PY, Qian M, Zhang H, Chen X, Ma D, Xu Y, Chen X, Tang KF (2016) The Fra-1-miR-134-SDS22 feedback loop amplifies ERK\/JNK signaling and reduces chemosensitivity in ovarian cancer cells. Cell Death Dis 7(9):e2384. \nhttps:\/\/doi.org\/10.1038\/cddis.2016.289","journal-title":"Cell Death Dis"},{"key":"5123_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2407-7-17","volume":"7","author":"G Chiappetta","year":"2007","unstructured":"Chiappetta G, Ferraro A, Botti G, Monaco M, Pasquinelli R, Vuttariello E, Arnaldi L, Di Bonito M, D\u2019Aiuto G, Pierantoni GM, Fusco A (2007) FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 7:17. \nhttps:\/\/doi.org\/10.1186\/1471-2407-7-17","journal-title":"BMC Cancer"},{"issue":"4","key":"5123_CR42","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2559.2011.03785.x","volume":"58","author":"AF Logullo","year":"2011","unstructured":"Logullo AF, Stiepcich MM, Osorio CA, Nonogaki S, Pasini FS, Rocha RM, Soares FA, Brentani MM (2011) Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma. Histopathology 58(4):617\u2013625. \nhttps:\/\/doi.org\/10.1111\/j.1365-2559.2011.03785.x","journal-title":"Histopathology"},{"key":"5123_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/1471-2407-13-441","volume":"13","author":"A Kharman-Biz","year":"2013","unstructured":"Kharman-Biz A, Gao H, Ghiasvand R, Zhao C, Zendehdel K, Dahlman-Wright K (2013) Expression of activator protein-1 (AP-1) family members in breast cancer. BMC Cancer 13:441. \nhttps:\/\/doi.org\/10.1186\/1471-2407-13-441","journal-title":"BMC Cancer"},{"issue":"3","key":"5123_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/07357900802254008","volume":"27","author":"K Ma","year":"2009","unstructured":"Ma K, Chang D, Gong M, Ding F, Luo A, Tian F, Liu Z, Wang T (2009) Expression and significance of FRA-1 in non-small-cell lung cancer. Cancer Invest 27(3):353\u2013359. \nhttps:\/\/doi.org\/10.1080\/07357900802254008","journal-title":"Cancer Invest"},{"issue":"1","key":"5123_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/or.2015.4395","volume":"35","author":"G Zhong","year":"2016","unstructured":"Zhong G, Chen X, Fang X, Wang D, Xie M, Chen Q (2016) Fra-1 is upregulated in lung cancer tissues and inhibits the apoptosis of lung cancer cells by the P53 signaling pathway. Oncol Rep 35(1):447\u2013453. \nhttps:\/\/doi.org\/10.3892\/or.2015.4395","journal-title":"Oncol Rep"},{"issue":"4","key":"5123_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ijc.10630","volume":"101","author":"HL Wang","year":"2002","unstructured":"Wang HL, Wang J, Xiao SY, Haydon R, Stoiber D, He TC, Bissonnette M, Hart J (2002) Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 101(4):301\u2013310. \nhttps:\/\/doi.org\/10.1002\/ijc.10630","journal-title":"Int J Cancer"},{"issue":"6","key":"5123_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ijc.20668","volume":"113","author":"BK Prusty","year":"2005","unstructured":"Prusty BK, Das BC (2005) Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113(6):951\u2013960. \nhttps:\/\/doi.org\/10.1002\/ijc.20668","journal-title":"Int J Cancer"},{"issue":"4","key":"5123_CR48","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3892\/ijo.2015.2873","volume":"46","author":"S Xiao","year":"2015","unstructured":"Xiao S, Zhou Y, Yi W, Luo G, Jiang B, Tian Q, Li Y, Xue M (2015) Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro. Int J Oncol 46(4):1677\u20131684. \nhttps:\/\/doi.org\/10.3892\/ijo.2015.2873","journal-title":"Int J Oncol"},{"issue":"1","key":"5123_CR49","first-page":"177","volume":"22","author":"S Hein","year":"2009","unstructured":"Hein S, Mahner S, Kanowski C, Loning T, Janicke F, Milde-Langosch K (2009) Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines. Oncol Rep 22(1):177\u2013183","journal-title":"Oncol Rep"},{"issue":"24","key":"5123_CR50","first-page":"8609","volume":"22","author":"YZ Luo","year":"2018","unstructured":"Luo YZ, He P, Qiu MX (2018) FOSL1 enhances growth and metastasis of human prostate cancer cells through epithelial mesenchymal transition pathway. Eur Rev Med Pharmacol 22(24):8609\u20138615","journal-title":"Eur Rev Med Pharmacol"},{"issue":"4","key":"5123_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.0959-9673.2005.00423.x","volume":"86","author":"FR Mangone","year":"2005","unstructured":"Mangone FR, Brentani MM, Nonogaki S, Begnami MD, Campos AH, Walder F, Carvalho MB, Soares FA, Torloni H, Kowalski LP, Federico MH (2005) Overexpression of Fos-Related antigen-1 in head and neck squamous cell carcinoma. Int J Exp Pathol 86(4):205\u2013212. \nhttps:\/\/doi.org\/10.1111\/j.0959-9673.2005.00423.x","journal-title":"Int J Exp Pathol"},{"issue":"4","key":"5123_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ijc.24807","volume":"126","author":"A Mishra","year":"2010","unstructured":"Mishra A, Bharti AC, Saluja D, Das BC (2010) Transactivation and expression patterns of Jun and Fos\/AP-1 super-family proteins in human oral cancer. Int J Cancer 126(4):819\u2013829. \nhttps:\/\/doi.org\/10.1002\/ijc.24807","journal-title":"Int J Cancer"},{"key":"5123_CR53","doi-asserted-by":"publisher","first-page":"16811","DOI":"10.1038\/srep16811","volume":"5","author":"S Gupta","year":"2015","unstructured":"Gupta S, Kumar P, Kaur H, Sharma N, Saluja D, Bharti AC, Das BC (2015) Selective participation of c-Jun with Fra-2\/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer. Sci Rep 5:16811. \nhttps:\/\/doi.org\/10.1038\/srep16811","journal-title":"Sci Rep"},{"issue":"3","key":"5123_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/sj.onc.1201953","volume":"17","author":"S Battista","year":"1998","unstructured":"Battista S, de Nigris F, Fedele M, Chiappetta G, Scala S, Vallone D, Pierantoni GM, Mega T, Santoro M, Viglietto G, Verde P, Fusco A (1998) Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene 17(3):377\u2013385. \nhttps:\/\/doi.org\/10.1038\/sj.onc.1201953","journal-title":"Oncogene"},{"issue":"11","key":"5123_CR55","first-page":"4300","volume":"6","author":"G Chiappetta","year":"2000","unstructured":"Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, Losito S, Fedele M, Battista S, Verde P, Santoro M, Fusco A (2000) FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res 6(11):4300\u20134306","journal-title":"Clin Cancer Res"},{"issue":"2","key":"5123_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3904\/kjim.2001.16.2.93","volume":"16","author":"YH Kim","year":"2001","unstructured":"Kim YH, Oh JH, Kim NH, Choi KM, Kim SJ, Baik SH, Choi DS, Lee ES (2001) Fra-1 expression in malignant and benign thyroid tumor. Korean J Intern Med 16(2):93\u201397","journal-title":"Korean J Intern Med"},{"issue":"13","key":"5123_CR57","first-page":"3759","volume":"62","author":"MM Serewko","year":"2002","unstructured":"Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM, Coman W, Dicker AJ, Saunders NA (2002) Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res 62(13):3759\u20133765","journal-title":"Cancer Res"},{"issue":"12","key":"5123_CR58","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/onc.2011.336","volume":"31","author":"AE Sayan","year":"2012","unstructured":"Sayan AE, Stanford R, Vickery R, Grigorenko E, Diesch J, Kulbicki K, Edwards R, Pal R, Greaves P, Jariel-Encontre I, Piechaczyk M, Kriajevska M, Mellon JK, Dhillon AS, Tulchinsky E (2012) Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL. Oncogene 31(12):1493\u20131503. \nhttps:\/\/doi.org\/10.1038\/onc.2011.336","journal-title":"Oncogene"},{"issue":"9","key":"5123_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s004320100255","volume":"127","author":"AM Bamberger","year":"2001","unstructured":"Bamberger AM, Milde-Langosch K, Rossing E, Goemann C, Loning T (2001) Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 127(9):545\u2013550","journal-title":"J Cancer Res Clin Oncol"},{"issue":"26","key":"5123_CR60","doi-asserted-by":"publisher","first-page":"39996","DOI":"10.18632\/oncotarget.9557","volume":"7","author":"RL Hanson","year":"2016","unstructured":"Hanson RL, Brown RB, Steele MM, Grandgenett PM, Grunkemeyer JA, Hollingsworth MA (2016) Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget 7(26):39996\u201340011. \nhttps:\/\/doi.org\/10.18632\/oncotarget.9557","journal-title":"Oncotarget"},{"key":"5123_CR61","doi-asserted-by":"publisher","first-page":"14294","DOI":"10.1038\/ncomms14294","volume":"8","author":"A Vallejo","year":"2017","unstructured":"Vallejo A, Perurena N, Guruceaga E, Mazur PK, Martinez-Canarias S, Zandueta C, Valencia K, Arricibita A, Gwinn D, Sayles LC, Chuang CH, Guembe L, Bailey P, Chang DK, Biankin A, Ponz-Sarvise M, Andersen JB, Khatri P, Bozec A, Sweet-Cordero EA, Sage J, Lecanda F, Vicent S (2017) An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Nat Commun 8:14294. \nhttps:\/\/doi.org\/10.1038\/ncomms14294","journal-title":"Nat Commun"},{"issue":"6","key":"5123_CR62","doi-asserted-by":"publisher","first-page":"101042831770963","DOI":"10.1177\/1010428317709635","volume":"39","author":"XQ Gao","year":"2017","unstructured":"Gao XQ, Ge YS, Shu QH, Ma HX (2017) Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance. Tumour Biol 39(6):1010428317709635. \nhttps:\/\/doi.org\/10.1177\/1010428317709635","journal-title":"Tumour Biol"},{"key":"5123_CR63","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_595_18","author":"L Li","year":"2019","unstructured":"Li L, Zhang W, Zhao S, Sun M (2019) FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma. Saudi J Gastroenterol. \nhttps:\/\/doi.org\/10.4103\/sjg.SJG_595_18","journal-title":"Saudi J Gastroenterol"},{"issue":"5","key":"5123_CR64","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3892\/ijo.2015.3146","volume":"47","author":"J He","year":"2015","unstructured":"He J, Zhu G, Gao L, Chen P, Long Y, Liao S, Yi H, Yi W, Pei Z, Wu M, Li X, Xiang J, Peng S, Ma J, Zhou M, Xiong W, Zeng Z, Xiang B, Tang K, Cao L, Li G, Zhou Y (2015) Fra-1 is upregulated in gastric cancer tissues and affects the PI3K\/Akt and p53 signaling pathway in gastric cancer. Int J Oncol 47(5):1725\u20131734. \nhttps:\/\/doi.org\/10.3892\/ijo.2015.3146","journal-title":"Int J Oncol"},{"issue":"6","key":"5123_CR65","doi-asserted-by":"publisher","first-page":"152394","DOI":"10.1016\/j.prp.2019.03.022","volume":"215","author":"X Zhu","year":"2019","unstructured":"Zhu X, Liu H, Xu Z, Zhang Y (2019) Expression and clinical significance of FOS-like antigen 1 in gastric adenocarcinoma. Pathol Res Pract 215(6):152394. \nhttps:\/\/doi.org\/10.1016\/j.prp.2019.03.022","journal-title":"Pathol Res Pract"},{"issue":"36","key":"5123_CR66","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/onc.2017.135","volume":"36","author":"K Maurus","year":"2017","unstructured":"Maurus K, Hufnagel A, Geiger F, Graf S, Berking C, Heinemann A, Paschen A, Kneitz S, Stigloher C, Geissinger E, Otto C, Bosserhoff A, Schartl M, Meierjohann S (2017) The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation. Oncogene 36(36):5110\u20135121. \nhttps:\/\/doi.org\/10.1038\/onc.2017.135","journal-title":"Oncogene"},{"issue":"8","key":"5123_CR67","first-page":"2213","volume":"7","author":"YC Hu","year":"2001","unstructured":"Hu YC, Lam KY, Law S, Wong J, Srivastava G (2001) Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 7(8):2213\u20132221","journal-title":"Clin Cancer Res"},{"key":"5123_CR68","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/1471-2407-9-329","volume":"9","author":"S Hussain","year":"2009","unstructured":"Hussain S, Bharti AC, Salam I, Bhat MA, Mir MM, Hedau S, Siddiqi MA, Basir SF, Das BC (2009) Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection. BMC Cancer 9:329. \nhttps:\/\/doi.org\/10.1186\/1471-2407-9-329","journal-title":"BMC Cancer"},{"key":"5123_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1476-4598-6-81","volume":"6","author":"ME Ramos-Nino","year":"2007","unstructured":"Ramos-Nino ME, Blumen SR, Pass H, Mossman BT (2007) Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas. Mol Cancer 6:81. \nhttps:\/\/doi.org\/10.1186\/1476-4598-6-81","journal-title":"Mol Cancer"},{"issue":"1","key":"5123_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1158\/1078-0432.CCR-07-1990","volume":"14","author":"J Wykosky","year":"2008","unstructured":"Wykosky J, Gibo DM, Stanton C, Debinski W (2008) Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy. Clin Cancer Res 14(1):199\u2013208. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1990","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5123_CR71","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1002\/jcp.27048","volume":"234","author":"Y Han","year":"2019","unstructured":"Han Y, Zhao XY, Sun YF, Sui YT, Liu JG (2019) Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK\/AP-1 signaling pathway. J Cell Physiol 234(4):3598\u20133612. \nhttps:\/\/doi.org\/10.1002\/jcp.27048","journal-title":"J Cell Physiol"},{"issue":"2","key":"5123_CR72","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115\u2013132. \nhttps:\/\/doi.org\/10.3322\/caac.21338","journal-title":"CA Cancer J Clin"},{"key":"5123_CR73","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. \nhttps:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"5123_CR74","doi-asserted-by":"publisher","first-page":"11011","DOI":"10.1093\/nar\/gku814","volume":"42","author":"G Moquet-Torcy","year":"2014","unstructured":"Moquet-Torcy G, Tolza C, Piechaczyk M, Jariel-Encontre I (2014) Transcriptional complexity and roles of Fra-1\/AP-1 at the uPA\/Plau locus in aggressive breast cancer. Nucleic Acids Res 42(17):11011\u201311024. \nhttps:\/\/doi.org\/10.1093\/nar\/gku814","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"5123_CR75","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/cdd.2014.157","volume":"22","author":"L Bakiri","year":"2015","unstructured":"Bakiri L, Macho-Maschler S, Custic I, Niemiec J, Guio-Carrion A, Hasenfuss SC, Eger A, Muller M, Beug H, Wagner EF (2015) Fra-1\/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1\/2 and TGFbeta expression. Cell Death Differ 22(2):336\u2013350. \nhttps:\/\/doi.org\/10.1038\/cdd.2014.157","journal-title":"Cell Death Differ"},{"issue":"1","key":"5123_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13058-018-0936-8","volume":"20","author":"MG Annis","year":"2018","unstructured":"Annis MG, Ouellet V, Rennhack JP, L\u2019Esperance S, Rancourt C, Mes-Masson AM, Andrechek ER, Siegel PM (2018) Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion. Breast Cancer Res 20(1):9. \nhttps:\/\/doi.org\/10.1186\/s13058-018-0936-8","journal-title":"Breast Cancer Res"},{"issue":"10","key":"5123_CR77","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00432-015-1925-2","volume":"141","author":"L Oliveira-Ferrer","year":"2015","unstructured":"Oliveira-Ferrer L, Kurschner M, Labitzky V, Wicklein D, Muller V, Luers G, Schumacher U, Milde-Langosch K, Schroder C (2015) Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties. J Cancer Res Clin Oncol 141(10):1715\u20131726. \nhttps:\/\/doi.org\/10.1007\/s00432-015-1925-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"5123_CR78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1101\/gr.226019.117","volume":"28","author":"HL Franco","year":"2018","unstructured":"Franco HL, Nagari A, Malladi VS, Li W, Xi Y, Richardson D, Allton KL, Tanaka K, Li J, Murakami S, Keyomarsi K, Bedford MT, Shi X, Li W, Barton MC, Dent SYR, Kraus WL (2018) Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis. Genome Res 28(2):159\u2013170. \nhttps:\/\/doi.org\/10.1101\/gr.226019.117","journal-title":"Genome Res"},{"issue":"1","key":"5123_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1590\/1678-4685-gmb-2017-0267","volume":"42","author":"LTR Serino","year":"2019","unstructured":"Serino LTR, Jucoski TS, Morais SB, Fernandes CCC, Lima RS, Urban CA, Cavalli LR, Cavalli IJ, Ribeiro E (2019) Association of FOSL1 copy number alteration and triple negative breast tumors. Genet Mol Biol 42(1):26\u201331. \nhttps:\/\/doi.org\/10.1590\/1678-4685-gmb-2017-0267","journal-title":"Genet Mol Biol"},{"issue":"28","key":"5123_CR80","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41388-019-0824-4","volume":"38","author":"H He","year":"2019","unstructured":"He H, Song DD, Sinha I, Hessling B, Li XD, Haldosen LA, Zhao CY (2019) Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1. Oncogene 38(28):5725\u20135738. \nhttps:\/\/doi.org\/10.1038\/s41388-019-0824-4","journal-title":"Oncogene"},{"key":"5123_CR81","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0036","author":"C Tolza","year":"2019","unstructured":"Tolza C, Bejjani F, Evanno E, Mahfoud S, Moquet-Torcy G, Gostan T, Maqbool MA, Kirsh O, Piechaczyk M, Jariel-Encontre I (2019) AP-1 signaling by Fra-1 directly regulates HMGA1 oncogene transcription in triple-negative breast cancers. Mol Cancer Res. \nhttps:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0036","journal-title":"Mol Cancer Res"},{"issue":"4","key":"5123_CR82","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ctrv.2015.02.008","volume":"41","author":"SL Wood","year":"2015","unstructured":"Wood SL, Pernemalm M, Crosbie PA, Whetton AD (2015) Molecular histology of lung cancer: from targets to treatments. Cancer Treat Rev 41(4):361\u2013375. \nhttps:\/\/doi.org\/10.1016\/j.ctrv.2015.02.008","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"5123_CR83","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1165\/rcmb.2017-0164OC","volume":"58","author":"IM Elangovan","year":"2018","unstructured":"Elangovan IM, Vaz M, Tamatam CR, Potteti HR, Reddy NM, Reddy SP (2018) FOSL1 promotes Kras-induced lung cancer through amphiregulin and cell survival gene regulation. Am J Respir Cell Mol Biol 58(5):625\u2013635. \nhttps:\/\/doi.org\/10.1165\/rcmb.2017-0164OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"5123_CR84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17476348.2017.1267571","volume":"11","author":"AM Rojewski","year":"2017","unstructured":"Rojewski AM, Zuromski KL, Toll BA (2017) Strategies for smoking cessation among high risk populations to prevent lung cancer. Expert Rev Respir Med 11(2):85\u201387. \nhttps:\/\/doi.org\/10.1080\/17476348.2017.1267571","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"5123_CR85","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1165\/rcmb.2014-0118OC","volume":"53","author":"M Vaz","year":"2015","unstructured":"Vaz M, Rajasekaran S, Potteti HR, Reddy SP (2015) Myeloid-specific Fos-related antigen-1 regulates cigarette smoke-induced lung inflammation, not emphysema, in mice. Am J Respir Cell Mol Biol 53(1):125\u2013134. \nhttps:\/\/doi.org\/10.1165\/rcmb.2014-0118OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"5123_CR86","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1165\/rcmb.2004-0198OC","volume":"32","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Adiseshaiah P, Reddy SP (2005) Matrix metalloproteinase\/epidermal growth factor receptor\/mitogen-activated protein kinase signaling regulate fra-1 induction by cigarette smoke in lung epithelial cells. Am J Respir Cell Mol Biol 32(1):72\u201381. \nhttps:\/\/doi.org\/10.1165\/rcmb.2004-0198OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"15","key":"5123_CR87","doi-asserted-by":"publisher","first-page":"10174","DOI":"10.1074\/jbc.M513008200","volume":"281","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Adiseshaiah P, Kalvakolanu DV, Reddy SP (2006) A Phosphatidylinositol 3-kinase-regulated Akt-independent signaling promotes cigarette smoke-induced FRA-1 expression. J Biol Chem 281(15):10174\u201310181. \nhttps:\/\/doi.org\/10.1074\/jbc.M513008200","journal-title":"J Biol Chem"},{"issue":"25","key":"5123_CR88","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.2217\/fon-2018-0043","volume":"14","author":"X Hu","year":"2018","unstructured":"Hu X, Peng N, Qi F, Li J, Shi L, Chen R (2018) Cigarette smoke upregulates SPRR3 by favoring c-Jun\/Fra1 heterodimerization in human bronchial epithelial cells. Future Oncol 14(25):2599\u20132613. \nhttps:\/\/doi.org\/10.2217\/fon-2018-0043","journal-title":"Future Oncol"},{"issue":"23","key":"5123_CR89","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2217\/nnm-2017-0205","volume":"12","author":"L Rubio","year":"2017","unstructured":"Rubio L, Bach J, Marcos R, Hernandez A (2017) Synergistic role of nanoceria on the ability of tobacco smoke to induce carcinogenic hallmarks in lung epithelial cells. Nanomedicine (Lond) 12(23):2623\u20132635. \nhttps:\/\/doi.org\/10.2217\/nnm-2017-0205","journal-title":"Nanomedicine (Lond)"},{"issue":"21","key":"5123_CR90","doi-asserted-by":"publisher","first-page":"7780","DOI":"10.1158\/0008-5472.CAN-04-1365","volume":"64","author":"A Shukla","year":"2004","unstructured":"Shukla A, Flanders T, Lounsbury KM, Mossman BT (2004) The gamma-glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity. Cancer Res 64(21):7780\u20137786. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1365","journal-title":"Cancer Res"},{"issue":"41","key":"5123_CR91","doi-asserted-by":"publisher","first-page":"43146","DOI":"10.18632\/oncotarget.6454","volume":"6","author":"S Iskit","year":"2015","unstructured":"Iskit S, Schlicker A, Wessels L, Peeper DS (2015) Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival. Oncotarget 6(41):43146\u201343161. \nhttps:\/\/doi.org\/10.18632\/oncotarget.6454","journal-title":"Oncotarget"},{"issue":"3","key":"5123_CR92","doi-asserted-by":"publisher","first-page":"e88950","DOI":"10.1371\/journal.pone.0088950","volume":"9","author":"J Diesch","year":"2014","unstructured":"Diesch J, Sanij E, Gilan O, Love C, Tran H, Fleming NI, Ellul J, Amalia M, Haviv I, Pearson RB, Tulchinsky E, Mariadason JM, Sieber OM, Hannan RD, Dhillon AS (2014) Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells. PLoS ONE 9(3):e88950. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0088950","journal-title":"PLoS ONE"},{"issue":"1","key":"5123_CR93","first-page":"77","volume":"30","author":"J de Wilde","year":"2008","unstructured":"de Wilde J, De-Castro Arce J, Snijders PJ, Meijer CJ, Rosl F, Steenbergen RD (2008) Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol 30(1):77\u201387","journal-title":"Cell Oncol"},{"issue":"7579","key":"5123_CR94","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1038\/527S217a","volume":"527","author":"D Holmes","year":"2015","unstructured":"Holmes D (2015) Ovarian cancer: beyond resistance. Nature 527(7579):S217. \nhttps:\/\/doi.org\/10.1038\/527S217a","journal-title":"Nature"},{"issue":"26","key":"5123_CR95","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1038\/sj.onc.1207585","volume":"23","author":"OI Tchernitsa","year":"2004","unstructured":"Tchernitsa OI, Sers C, Zuber J, Hinzmann B, Grips M, Schramme A, Lund P, Schwendel A, Rosenthal A, Schafer R (2004) Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23(26):4536\u20134555. \nhttps:\/\/doi.org\/10.1038\/sj.onc.1207585","journal-title":"Oncogene"},{"issue":"8","key":"5123_CR96","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/sj.bjc.6604650","volume":"99","author":"S Mahner","year":"2008","unstructured":"Mahner S, Baasch C, Schwarz J, Hein S, Wolber L, Janicke F, Milde-Langosch K (2008) C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer 99(8):1269\u20131275. \nhttps:\/\/doi.org\/10.1038\/sj.bjc.6604650","journal-title":"Br J Cancer"},{"issue":"3","key":"5123_CR97","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/bjc.2013.774","volume":"110","author":"L Oliveira-Ferrer","year":"2014","unstructured":"Oliveira-Ferrer L, Rossler K, Haustein V, Schroder C, Wicklein D, Maltseva D, Khaustova N, Samatov T, Tonevitsky A, Mahner S, Janicke F, Schumacher U, Milde-Langosch K (2014) c-FOS suppresses ovarian cancer progression by changing adhesion. Br J Cancer 110(3):753\u2013763. \nhttps:\/\/doi.org\/10.1038\/bjc.2013.774","journal-title":"Br J Cancer"},{"issue":"6","key":"5123_CR98","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.3892\/or.2017.6052","volume":"38","author":"Y Hao","year":"2017","unstructured":"Hao Y, Zhu L, Yan L, Liu J, Liu D, Gao N, Tan M, Gao S, Lin B (2017) c-Fos mediates alpha1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-beta1 in ovarian cancer. Oncol Rep 38(6):3355\u20133366. \nhttps:\/\/doi.org\/10.3892\/or.2017.6052","journal-title":"Oncol Rep"},{"key":"5123_CR99","doi-asserted-by":"publisher","first-page":"41737","DOI":"10.1038\/srep41737","volume":"7","author":"W Liu","year":"2017","unstructured":"Liu W, Tian T, Liu L, Du J, Gu Y, Qin N, Yan C, Wang Z, Dai J, Fan Z (2017) A functional SNP rs1892901 in FOSL1 is associated with gastric cancer in Chinese population. Sci Rep 7:41737. \nhttps:\/\/doi.org\/10.1038\/srep41737","journal-title":"Sci Rep"},{"key":"5123_CR100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.micpath.2019.02.022","volume":"129","author":"Y Yang","year":"2019","unstructured":"Yang Y, Dong K, Shao S (2019) The effect of Helicobacter pylori on the expression of FRA-1 in gastric epithelial cells and its mechanism. Microb Pathog 129:257\u2013265. \nhttps:\/\/doi.org\/10.1016\/j.micpath.2019.02.022","journal-title":"Microb Pathog"},{"issue":"12","key":"5123_CR101","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1128\/JVI.67.12.7001-7007.1993","volume":"67","author":"H Tsuchiya","year":"1993","unstructured":"Tsuchiya H, Fujii M, Niki T, Tokuhara M, Matsui M, Seiki M (1993) Human T-cell leukemia virus type 1 Tax activates transcription of the human fra-1 gene through multiple cis elements responsive to transmembrane signals. J Virol 67(12):7001\u20137007","journal-title":"J Virol"},{"issue":"3","key":"5123_CR102","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1053\/j.gastro.2018.05.041","volume":"155","author":"RK Nimmakayala","year":"2018","unstructured":"Nimmakayala RK, Seshacharyulu P, Lakshmanan I, Rachagani S, Chugh S, Karmakar S, Rauth S, Vengoji R, Atri P, Talmon GA, Lele SM, Smith LM, Thapa I, Bastola D, Ouellette MM, Batra SK, Ponnusamy MP (2018) Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1. Gastroenterology 155(3):892. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2018.05.041","journal-title":"Gastroenterology"},{"issue":"8","key":"5123_CR103","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.oraloncology.2011.06.003","volume":"47","author":"L Zhang","year":"2011","unstructured":"Zhang L, Ye DX, Pan HY, Wei KJ, Wang LZ, Wang XD, Shen GF, Zhang ZY (2011) Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma. Oral Oncol 47(8):693\u2013697. \nhttps:\/\/doi.org\/10.1016\/j.oraloncology.2011.06.003","journal-title":"Oral Oncol"},{"issue":"1","key":"5123_CR104","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1038\/s41598-017-05106-5","volume":"7","author":"H Xu","year":"2017","unstructured":"Xu H, Jin X, Yuan Y, Deng P, Jiang L, Zeng X, Li XS, Wang ZY, Chen QM (2017) Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study. Sci Rep 7(1):7522. \nhttps:\/\/doi.org\/10.1038\/s41598-017-05106-5","journal-title":"Sci Rep"},{"issue":"3","key":"5123_CR105","doi-asserted-by":"publisher","first-page":"867","DOI":"10.22034\/APJCP.2018.19.3.867","volume":"19","author":"A Krishna","year":"2018","unstructured":"Krishna A, Bhatt MLB, Singh V, Singh S, Gangwar PK, Singh US, Kumar V, Mehrotra D (2018) Differential expression of c-fos proto-oncogene in normal oral mucosa versus squamous cell carcinoma. Asian Pac J Cancer Prev 19(3):867\u2013874. \nhttps:\/\/doi.org\/10.22034\/APJCP.2018.19.3.867","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"5123_CR106","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/1097-0215(20000815)87:4<468::AID-IJC2>3.0.CO;2-R","volume":"87","author":"K Milde-Langosch","year":"2000","unstructured":"Milde-Langosch K, Bamberger AM, Methner C, Rieck G, Loning T (2000) Expression of cell cycle-regulatory proteins Rb, p16\/MTS1, p27\/KIP1, p21\/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members. Int J Cancer 87(4):468\u2013472","journal-title":"Int J Cancer"},{"issue":"5","key":"5123_CR107","first-page":"1791","volume":"61","author":"A Shukla","year":"2001","unstructured":"Shukla A, Timblin CR, Hubbard AK, Bravman J, Mossman BT (2001) Silica-induced activation of c-Jun-NH2-terminal amino kinases, protracted expression of the activator protein-1 proto-oncogene, fra-1, and S-phase alterations are mediated via oxidative stress. Can Res 61(5):1791\u20131795","journal-title":"Can Res"},{"issue":"7","key":"5123_CR108","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/sj.emboj.7601617","volume":"26","author":"L Casalino","year":"2007","unstructured":"Casalino L, Bakiri L, Talotta F, Weitzman JB, Fusco A, Yaniv M, Verde P (2007) Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription. EMBO J 26(7):1878\u20131890. \nhttps:\/\/doi.org\/10.1038\/sj.emboj.7601617","journal-title":"EMBO J"},{"issue":"1","key":"5123_CR109","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-017-0555-8","volume":"36","author":"C Wang","year":"2017","unstructured":"Wang C, Li Z, Shao F, Yang X, Feng X, Shi S, Gao Y, He J (2017) High expression of collagen triple helix repeat containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK\/MEK\/ERK\/FRA-1 activation. J Exp Clin Cancer Res 36(1):84. \nhttps:\/\/doi.org\/10.1186\/s13046-017-0555-8","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"5123_CR110","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1165\/rcmb.2007-0206OC","volume":"38","author":"ME Ramos-Nino","year":"2008","unstructured":"Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Pass H, Carbone M, Testa JR, Altomare BA, Mossman BT (2008) HGF mediates cell proliferation of human mesothelioma cells through a PI3K\/MEK5\/Fra-1 pathway. Am J Resp Cell Mol 38(2):209\u2013217. \nhttps:\/\/doi.org\/10.1165\/rcmb.2007-0206OC","journal-title":"Am J Resp Cell Mol"},{"issue":"22","key":"5123_CR111","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1158\/0008-5472.Can-18-1040","volume":"78","author":"A Dikshit","year":"2018","unstructured":"Dikshit A, Jin YAJ, Degan S, Hwang J, Foster MW, Li CY, Zhang JY (2018) UBE2N promotes melanoma growth via MEK\/FRA1\/SOX10 signaling. Can Res 78(22):6462\u20136472. \nhttps:\/\/doi.org\/10.1158\/0008-5472.Can-18-1040","journal-title":"Can Res"},{"issue":"14","key":"5123_CR112","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1158\/0008-5472.CAN-13-3396","volume":"74","author":"C Zhao","year":"2014","unstructured":"Zhao C, Qiao Y, Jonsson P, Wang J, Xu L, Rouhi P, Sinha I, Cao Y, Williams C, Dahlman-Wright K (2014) Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer. Cancer Res 74(14):3983\u20133994. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3396","journal-title":"Cancer Res"},{"issue":"1","key":"5123_CR113","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1038\/s41598-018-32438-7","volume":"8","author":"X Wang","year":"2018","unstructured":"Wang X, Xu C, Hua Y, Cheng K, Zhang Y, Liu J, Han Y, Liu S, Zhang G, Xu S, Yang Z (2018) Psoralen induced cell cycle arrest by modulating Wnt\/beta-catenin pathway in breast cancer cells. Sci Rep 8(1):14001. \nhttps:\/\/doi.org\/10.1038\/s41598-018-32438-7","journal-title":"Sci Rep"},{"issue":"6","key":"5123_CR114","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.18632\/oncotarget.6797","volume":"7","author":"WW He","year":"2016","unstructured":"He WW, Wu YN, Tang XM, Xia Y, He GZ, Min ZQ, Li C, Xiong SQ, Shi Z, Lu YJ, Yuan ZM (2016) HDAC inhibitors suppress c-Jun\/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells. Oncotarget 7(6):6727\u20136747. \nhttps:\/\/doi.org\/10.18632\/oncotarget.6797","journal-title":"Oncotarget"},{"key":"5123_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1398-3","author":"BB Li","year":"2015","unstructured":"Li BB, Wan Z, Huang GL, Huang ZN, Zhang XN, Liao D, Luo SQ, He ZW (2015) Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes. BMC Cancer. \nhttps:\/\/doi.org\/10.1186\/s12885-015-1398-3","journal-title":"BMC Cancer"},{"issue":"1","key":"5123_CR116","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0014-4827(03)00346-X","volume":"291","author":"NV Shirsat","year":"2003","unstructured":"Shirsat NV, Shaikh SA (2003) Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of C6 glioma cells. Exp Cell Res 291(1):91\u2013100. \nhttps:\/\/doi.org\/10.1016\/S0014-4827(03)00346-X","journal-title":"Exp Cell Res"},{"issue":"1\u20132","key":"5123_CR117","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11010-017-3012-2","volume":"433","author":"K Kavya","year":"2017","unstructured":"Kavya K, Kumar MN, Patil RH, Hegde SM, Kiran Kumar KM, Nagesh R, Babu RL, Ramesh GT, Chidananda Sharma S (2017) Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status. Mol Cell Biochem 433(1\u20132):13\u201326. \nhttps:\/\/doi.org\/10.1007\/s11010-017-3012-2","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5123_CR118","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) Emt: 2016. Cell 166(1):21\u201345. \nhttps:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"key":"5123_CR119","doi-asserted-by":"publisher","first-page":"229","DOI":"10.12688\/f1000research.2-229.v1","volume":"2","author":"E Henckels","year":"2013","unstructured":"Henckels E, Prywes R (2013) Fra-1 regulation of Matrix Metallopeptidase-1 (MMP-1) in metastatic variants of MDA-MB-231 breast cancer cells. F1000Res 2:229. \nhttps:\/\/doi.org\/10.12688\/f1000research.2-229.v1","journal-title":"F1000Res"},{"issue":"1","key":"5123_CR120","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molimm.2007.04.031","volume":"45","author":"Y Song","year":"2008","unstructured":"Song Y, Qian L, Song S, Chen L, Zhang Y, Yuan G, Zhang H, Xia Q, Hu M, Yu M, Shi M, Jiang Z, Guo N (2008) Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene. Mol Immunol 45(1):137\u2013143. \nhttps:\/\/doi.org\/10.1016\/j.molimm.2007.04.031","journal-title":"Mol Immunol"},{"issue":"6","key":"5123_CR121","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1038\/oncsis.2017.44","volume":"6","author":"C Rattanasinchai","year":"2017","unstructured":"Rattanasinchai C, Llewellyn BJ, Conrad SE, Gallo KA (2017) MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells. Oncogenesis 6(6):e345. \nhttps:\/\/doi.org\/10.1038\/oncsis.2017.44","journal-title":"Oncogenesis"},{"issue":"5","key":"5123_CR122","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1517\/14728222.2015.1012156","volume":"19","author":"XF Wang","year":"2015","unstructured":"Wang XF, Zhou QM, Lu YY, Zhang H, Huang S, Su SB (2015) Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. Expert Opin Ther Targ 19(5):577\u2013587. \nhttps:\/\/doi.org\/10.1517\/14728222.2015.1012156","journal-title":"Expert Opin Ther Targ"},{"issue":"10","key":"5123_CR123","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.7150\/thno.29617","volume":"9","author":"P Jiang","year":"2019","unstructured":"Jiang P, Gao W, Ma T, Wang R, Piao Y, Dong X, Wang P, Zhang X, Liu Y, Su W, Xiang R, Zhang J, Li N (2019) CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes\/macrophages. Theranostics 9(10):2950\u20132966. \nhttps:\/\/doi.org\/10.7150\/thno.29617","journal-title":"Theranostics"},{"issue":"2","key":"5123_CR124","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jcp.21410","volume":"216","author":"P Adiseshaiah","year":"2008","unstructured":"Adiseshaiah P, Vaz M, Machireddy N, Kalvakolanu DV, Reddy SP (2008) A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion. J Cell Physiol 216(2):405\u2013412. \nhttps:\/\/doi.org\/10.1002\/jcp.21410","journal-title":"J Cell Physiol"},{"issue":"3","key":"5123_CR125","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1158\/0008-5472.CAN-18-1479","volume":"79","author":"M Roman","year":"2019","unstructured":"Roman M, Lopez I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Miguel ME, Jang JH, Martin-Uriz PS, Castro-Labrador L, Vilas-Zornoza A, Lara-Astiaso D, Ponz-Sarvise M, Rolfo C, Santos ES, Raez LE, Taverna S, Behrens C, Weder W, Wistuba II, Vicent S, Gil-Bazo I (2019) Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network. Cancer Res 79(3):625\u2013638. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1479","journal-title":"Cancer Res"},{"issue":"1","key":"5123_CR126","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10555-017-9726-5","volume":"37","author":"D Huang","year":"2018","unstructured":"Huang D, Sun W, Zhou Y, Li P, Chen F, Chen H, Xia D, Xu E, Lai M, Wu Y, Zhang H (2018) Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer Metastasis Rev 37(1):173\u2013187. \nhttps:\/\/doi.org\/10.1007\/s10555-017-9726-5","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"5123_CR127","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1053\/j.gastro.2005.09.002","volume":"129","author":"S Song","year":"2005","unstructured":"Song S, Byrd JC, Mazurek N, Liu K, Koo JS, Bresalier RS (2005) Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology 129(5):1581\u20131591. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2005.09.002","journal-title":"Gastroenterology"},{"issue":"8","key":"5123_CR128","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ijc.23309","volume":"122","author":"C Andreolas","year":"2008","unstructured":"Andreolas C, Kalogeropoulou M, Voulgari A, Pintzas A (2008) Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells. Int J Cancer 122(8):1745\u20131756. \nhttps:\/\/doi.org\/10.1002\/ijc.23309","journal-title":"Int J Cancer"},{"issue":"3","key":"5123_CR129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.14348\/molcells.2018.2113","volume":"41","author":"X Sun","year":"2018","unstructured":"Sun X, Zhang T, Deng Q, Zhou Q, Sun X, Li E, Yu D, Zhong C (2018) Benzidine induces epithelial-mesenchymal transition of human bladder cancer cells through activation of ERK5 pathway. Mol Cells 41(3):188\u2013197. \nhttps:\/\/doi.org\/10.14348\/molcells.2018.2113","journal-title":"Mol Cells"},{"issue":"6","key":"5123_CR130","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/hep.26255","volume":"57","author":"XY Huang","year":"2013","unstructured":"Huang XY, Ke AW, Shi GM, Zhang X, Zhang C, Shi YH, Wang XY, Ding ZB, Xiao YS, Yan J, Qiu SJ, Fan J, Zhou J (2013) alphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology 57(6):2235\u20132247. \nhttps:\/\/doi.org\/10.1002\/hep.26255","journal-title":"Hepatology"},{"issue":"11","key":"5123_CR131","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1245\/s10434-016-5666-5","volume":"24","author":"T Toyozumi","year":"2017","unstructured":"Toyozumi T, Hoshino I, Takahashi M, Usui A, Akutsu Y, Hanari N, Murakami K, Kano M, Akanuma N, Suitoh H, Matsumoto Y, Sekino N, Komatsu A, Matsubara H (2017) Fra-1 regulates the expression of HMGA1, which is associated with a poor prognosis in human esophageal squamous cell carcinoma. Ann Surg Oncol 24(11):3446\u20133455. \nhttps:\/\/doi.org\/10.1245\/s10434-016-5666-5","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"5123_CR132","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1128\/JVI.00174-12","volume":"86","author":"YY Lan","year":"2012","unstructured":"Lan YY, Hsiao JR, Chang KC, Chang JS, Chen CW, Lai HC, Wu SY, Yeh TH, Chang FH, Lin WH, Su IJ, Chang Y (2012) Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK\/Fra-1-mediated induction of matrix metalloproteinase 9. J Virol 86(12):6656\u20136667. \nhttps:\/\/doi.org\/10.1128\/JVI.00174-12","journal-title":"J Virol"},{"issue":"5","key":"5123_CR133","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, You MJ, DePinho RA, McMahon M, Bosenberg M (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41(5):544\u2013552. \nhttps:\/\/doi.org\/10.1038\/ng.356","journal-title":"Nat Genet"},{"issue":"4","key":"5123_CR134","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A, Saldanha G, Osborne J, Hutchinson P, Tse G, Lachuer J, Puisieux A, Pringle JH, Ansieau S, Tulchinsky E (2013) A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24(4):466\u2013480. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2013.08.018","journal-title":"Cancer Cell"},{"issue":"16","key":"5123_CR135","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1158\/0008-5472.CAN-17-3149","volume":"78","author":"HQ Duong","year":"2018","unstructured":"Duong HQ, Nemazanyy I, Rambow F, Tang SC, Delaunay S, Tharun L, Florin A, Buttner R, Vandaele D, Close P, Marine JC, Shostak K, Chariot A (2018) The endosomal protein CEMIP links WNT signaling to MEK1-ERK1\/2 activation in Selumetinib-resistant intestinal organoids. Cancer Res 78(16):4533\u20134548. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3149","journal-title":"Cancer Res"},{"issue":"3","key":"5123_CR136","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3892\/or.2018.6223","volume":"39","author":"S Endo","year":"2018","unstructured":"Endo S, Fujita M, Yamada S, Imadome K, Nakayama F, Isozaki T, Yasuda T, Imai T, Matsubara H (2018) Fra1 enhances the radioresistance of colon cancer cells to Xray or Cion radiation. Oncol Rep 39(3):1112\u20131118. \nhttps:\/\/doi.org\/10.3892\/or.2018.6223","journal-title":"Oncol Rep"},{"issue":"5","key":"5123_CR137","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3892\/ijo_00000434","volume":"35","author":"R Kajanne","year":"2009","unstructured":"Kajanne R, Miettinen P, Tenhunen M, Leppa S (2009) Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells. Int J Oncol 35(5):1175\u20131182. \nhttps:\/\/doi.org\/10.3892\/ijo_00000434","journal-title":"Int J Oncol"},{"issue":"5","key":"5123_CR138","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1124\/mol.107.043554","volume":"73","author":"P Javvadi","year":"2008","unstructured":"Javvadi P, Segan AT, Tuttle SW, Koumenis C (2008) The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73(5):1491\u20131501. \nhttps:\/\/doi.org\/10.1124\/mol.107.043554","journal-title":"Mol Pharmacol"},{"issue":"1","key":"5123_CR139","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1038\/s41598-017-05162-x","volume":"7","author":"A Tyagi","year":"2017","unstructured":"Tyagi A, Vishnoi K, Kaur H, Srivastava Y, Roy BG, Das BC, Bharti AC (2017) Cervical cancer stem cells manifest radioresistance: association with upregulated AP-1 activity. Sci Rep 7(1):4781. \nhttps:\/\/doi.org\/10.1038\/s41598-017-05162-x","journal-title":"Sci Rep"},{"issue":"9","key":"5123_CR140","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41389-018-0082-2","volume":"7","author":"J Grimm","year":"2018","unstructured":"Grimm J, Hufnagel A, Wobser M, Borst A, Haferkamp S, Houben R, Meierjohann S (2018) BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1. Oncogenesis 7(9):71. \nhttps:\/\/doi.org\/10.1038\/s41389-018-0082-2","journal-title":"Oncogenesis"},{"issue":"5","key":"5123_CR141","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.celrep.2016.06.091","volume":"16","author":"AM Kurimchak","year":"2016","unstructured":"Kurimchak AM, Shelton C, Duncan KE, Johnson KJ, Brown J, O\u2019Brien S, Gabbasov R, Fink LS, Li Y, Lounsbury N, Abou-Gharbia M, Childers WE, Connolly DC, Chernoff J, Peterson JR, Duncan JS (2016) Resistance to BET bromodomain inhibitors is mediated by kinome reprogramming in ovarian cancer. Cell Rep 16(5):1273\u20131286. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.06.091","journal-title":"Cell Rep"},{"issue":"8","key":"5123_CR142","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1158\/1541-7786.MCR-18-1332","volume":"17","author":"AM Kurimchak","year":"2019","unstructured":"Kurimchak AM, Shelton C, Herrera-Montavez C, Duncan KE, Chernoff J, Duncan JS (2019) Intrinsic resistance to MEK inhibition through BET protein-mediated kinome reprogramming in NF1-deficient ovarian cancer. Mol Cancer Res 17(8):1721\u20131734. \nhttps:\/\/doi.org\/10.1158\/1541-7786.MCR-18-1332","journal-title":"Mol Cancer Res"},{"issue":"29","key":"5123_CR143","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41388-018-0238-8","volume":"37","author":"W Zhou","year":"2018","unstructured":"Zhou W, Sun W, Yung MMH, Dai S, Cai Y, Chen CW, Meng Y, Lee JB, Braisted JC, Xu Y, Southall NT, Shinn P, Huang X, Song Z, Chen X, Kai Y, Cai X, Li Z, Hao Q, Cheung ANY, Ngan HYS, Liu SS, Barak S, Hao J, Dai Z, Tzatsos A, Peng W, Pei H, Han Z, Chan DW, Zheng W, Zhu W (2018) Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance. Oncogene 37(29):3981\u20133997. \nhttps:\/\/doi.org\/10.1038\/s41388-018-0238-8","journal-title":"Oncogene"},{"issue":"8","key":"5123_CR144","doi-asserted-by":"publisher","first-page":"816","DOI":"10.2174\/1568009617666170623101722","volume":"18","author":"I Zanellato","year":"2018","unstructured":"Zanellato I, Colangelo D, Osella D (2018) JQ1, a BET inhibitor, synergizes with cisplatin and induces apoptosis in highly chemoresistant malignant pleural mesothelioma cells. Curr Cancer Drug Targ 18(8):816\u2013828. \nhttps:\/\/doi.org\/10.2174\/1568009617666170623101722","journal-title":"Curr Cancer Drug Targ"},{"issue":"3","key":"5123_CR145","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jtho.2016.10.023","volume":"12","author":"H Cho","year":"2017","unstructured":"Cho H, Matsumoto S, Fujita Y, Kuroda A, Menju T, Sonobe M, Kondo N, Torii I, Nakano T, Lara PN, Gandara DR, Date H, Hasegawa S (2017) Trametinib plus 4-methylumbelliferone exhibits antitumor effects by ERK blockade and CD44 downregulation and affects PD-1 and PD-L1 in malignant pleural mesothelioma. J Thorac Oncol 12(3):477\u2013490. \nhttps:\/\/doi.org\/10.1016\/j.jtho.2016.10.023","journal-title":"J Thorac Oncol"},{"issue":"4","key":"5123_CR146","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/cas.13929","volume":"110","author":"W Yang","year":"2019","unstructured":"Yang W, Meng L, Chen K, Tian C, Peng B, Zhong L, Zhang C, Yang X, Zou J, Yang S, Li L (2019) Preclinical pharmacodynamic evaluation of a new Src\/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma. Cancer Sci 110(4):1408\u20131419. \nhttps:\/\/doi.org\/10.1111\/cas.13929","journal-title":"Cancer Sci"},{"issue":"34","key":"5123_CR147","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1038\/onc.2014.374","volume":"34","author":"AS Dhillon","year":"2015","unstructured":"Dhillon AS, Tulchinsky E (2015) FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer. Oncogene 34(34):4421\u20134428. \nhttps:\/\/doi.org\/10.1038\/onc.2014.374","journal-title":"Oncogene"},{"issue":"6","key":"5123_CR148","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","volume":"15","author":"EY Lau","year":"2016","unstructured":"Lau EY, Lo J, Cheng BY, Ma MK, Lee JM, Ng JK, Chai S, Lin CH, Tsang SY, Ma S, Ng IO, Lee TK (2016) Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met\/FRA1\/HEY1 signaling. Cell Rep 15(6):1175\u20131189. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.04.019","journal-title":"Cell Rep"},{"key":"5123_CR149","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fonc.2019.00544","volume":"9","author":"AC Racca","year":"2019","unstructured":"Racca AC, Prucca CG, Caputto BL (2019) Fra-1 and c-Fos N-terminal deletion mutants impair breast tumor cell proliferation by blocking lipid synthesis activation. Front Oncol 9:544. \nhttps:\/\/doi.org\/10.3389\/fonc.2019.00544","journal-title":"Front Oncol"},{"issue":"6","key":"5123_CR150","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/cr.2010.52","volume":"20","author":"Q Wang","year":"2010","unstructured":"Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y (2010) Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res 20(6):701\u2013712. \nhttps:\/\/doi.org\/10.1038\/cr.2010.52","journal-title":"Cell Res"},{"issue":"5","key":"5123_CR151","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/onc.2009.308","volume":"29","author":"YP Luo","year":"2010","unstructured":"Luo YP, Zhou H, Krueger J, Kaplan C, Liao D, Markowitz D, Liu C, Chen T, Chuang TH, Xiang R, Reisfeld RA (2010) The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene 29(5):662\u2013673. \nhttps:\/\/doi.org\/10.1038\/onc.2009.308","journal-title":"Oncogene"},{"issue":"6","key":"5123_CR152","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41419-019-1618-x","volume":"10","author":"Z Guo","year":"2019","unstructured":"Guo Z, Song J, Hao J, Zhao H, Du X, Li E, Kuang Y, Yang F, Wang W, Deng J, Wang Q (2019) M2 macrophages promote NSCLC metastasis by upregulating CRYAB. Cell Death Dis 10(6):377. \nhttps:\/\/doi.org\/10.1038\/s41419-019-1618-x","journal-title":"Cell Death Dis"},{"issue":"7547","key":"5123_CR153","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature14336","volume":"520","author":"AC Obenauf","year":"2015","unstructured":"Obenauf AC, Zou Y, Ji AL, Vanharanta S, Shu W, Shi H, Kong X, Bosenberg MC, Wiesner T, Rosen N, Lo RS, Massague J (2015) Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 520(7547):368\u2013372. \nhttps:\/\/doi.org\/10.1038\/nature14336","journal-title":"Nature"},{"issue":"7675","key":"5123_CR154","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature24037","volume":"550","author":"X Kong","year":"2017","unstructured":"Kong X, Kuilman T, Shahrabi A, Boshuizen J, Kemper K, Song JY, Niessen HWM, Rozeman EA, Geukes Foppen MH, Blank CU, Peeper DS (2017) Cancer drug addiction is relayed by an ERK2-dependent phenotype switch. Nature 550(7675):270\u2013274. \nhttps:\/\/doi.org\/10.1038\/nature24037","journal-title":"Nature"},{"issue":"1","key":"5123_CR155","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/2159-8290.CD-17-0682","volume":"8","author":"A Hong","year":"2018","unstructured":"Hong A, Moriceau G, Sun L, Lomeli S, Piva M, Damoiseaux R, Holmen SL, Sharpless NE, Hugo W, Lo RS (2018) Exploiting drug addiction mechanisms to select against MAPKi-resistant melanoma. Cancer Discov 8(1):74\u201393. \nhttps:\/\/doi.org\/10.1158\/2159-8290.CD-17-0682","journal-title":"Cancer Discov"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05123-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-05123-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05123-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T23:15:13Z","timestamp":1602544513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-05123-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5123"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-05123-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}